HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laparoscopic vs open resection of pT4 colon cancer: a propensity score analysis of 94 patients.

AbstractAIM:
Our aim was to compare short- and long-term oncological outcomes between laparoscopic and open colectomy in T4 colon cancer.
METHODS:
We retrospectively analysed oncological outcomes of 94 patients who underwent surgery between December 2010 and December 2016 for pT4 colon cancer, with propensity score matching. All patients were treated with curative intent, by either laparoscopic or open en bloc resection.
RESULTS:
The conversion rate in the laparoscopic group was 17.0%. Blood loss, time to flatus and postoperative hospitalization were significantly less in the laparoscopic group. Postoperative morbidity and mortality within 30 days did not significantly differ between the two groups. R0 resection rates and lymph node harvests were similar between the two groups. At 5 years, laparoscopic outcomes were not inferior to open outcomes (overall survival 56.8% vs 50.2%, P = 0.250; disease-free survival 59.7% vs 41.7%, P = 0.06).
CONCLUSION:
The laparoscopic approach is safe and feasible for pathologically confirmed T4 colon cancer. It results in a faster postoperative recovery.
AuthorsX Yang, M-E Zhong, Y Xiao, G-N Zhang, L Xu, J Lu, G Lin, H Qiu, B Wu
JournalColorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (Colorectal Dis) Vol. 20 Issue 11 Pg. O316-O325 (11 2018) ISSN: 1463-1318 [Electronic] England
PMID30240536 (Publication Type: Comparative Study, Journal Article)
CopyrightColorectal Disease © 2018 The Association of Coloproctology of Great Britain and Ireland.
Topics
  • Aged
  • Colectomy (methods, mortality)
  • Colonic Neoplasms (mortality, pathology, surgery)
  • Disease-Free Survival
  • Feasibility Studies
  • Female
  • Humans
  • Laparoscopy (methods, mortality)
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Propensity Score
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: